Paula Ribó
Impact in
- Immunology and Allergy top 5%
- Allergic Rhinitis and Sensitization
- Otorhinolaryngology top 10%
- Sinusitis and nasal conditions
Papers in
-
- Urticaria and Related Conditions 5
-
- Asthma and respiratory diseases 7
- Co-authors
- Rosa Muñoz‐Cano (10 shared papers)Antonio Valero (8 shared papers)Vicente Plaza (4 shared papers)Myriam Calle Rubio (3 shared papers)Carlos Campo (3 shared papers)Paula H. Rytilä (3 shared papers)Jaime Sánchez-López (1 shared paper)Joaquim Mullol (5 shared papers)
In The Last Decade
Paula Ribó
20 papers receiving 313 citations
Peers
Comparison fields: 5 of 43
- Immunology and Allergy 69
- Otorhinolaryngology 29
- Family Practice 11
- Physiology 108
- Rheumatology 41
Countries citing papers authored by Paula Ribó
This map shows the geographic impact of Paula Ribó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paula Ribó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paula Ribó more than expected).
Fields of papers citing papers by Paula Ribó
This network shows the impact of papers produced by Paula Ribó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paula Ribó. The network helps show where Paula Ribó may publish in the future.
Co-authors
The 25 scholars most cited alongside Paula Ribó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 58 | |
| 2 | 2020 | 53 | |
| 3 | 2023 | 50 | |
| 4 | 2018 | 46 | |
| 5 | 2019 | 34 | |
| 6 | 2022 | 20 | |
| 7 | 2019 | 19 | |
| 8 | 2020 | 11 | |
| 9 | 2025 | 7 | |
| 10 | 2022 | 5 | |
| 11 | 2024 | 4 | |
| 12 | 2013 | 3 | |
| 13 | 2018 | 3 | |
| 14 | 2023 | 3 | |
| 15 | 2023 | 2 | |
| 16 | 2023 | 2 | |
| 17 | 2024 | 2 | |
| 18 | 2025 | 2 | |
| 19 | 2024 | 1 | |
| 20 | 2025 | 1 |
About Paula Ribó
Paula Ribó is a scholar working on Rheumatology, Physiology, Immunology and Allergy, Otorhinolaryngology and Dermatology, having authored 21 papers that have together received 326 indexed citations. Recurring topics across this work include Asthma and respiratory diseases (7 papers), Urticaria and Related Conditions (5 papers), Sinusitis and nasal conditions (3 papers), Dermatology and Skin Diseases (3 papers), Allergic Rhinitis and Sensitization (3 papers), Medication Adherence and Compliance (1 paper), Gastroesophageal reflux and treatments (1 paper) and Respiratory and Cough-Related Research (1 paper). The work is most often cited by research in Immunology and Allergy (69 citations), Otorhinolaryngology (29 citations), Family Practice (11 citations), Physiology (108 citations) and Rheumatology (41 citations). Paula Ribó has collaborated with scholars based in Spain and Finland. Frequent co-authors include Rosa Muñoz‐Cano, Antonio Valero, Vicente Plaza, Myriam Calle Rubio, Carlos Campo, Paula H. Rytilä, Jaime Sánchez-López, Joaquim Mullol, Eva Giralt and Jordi Giner. Their work appears in journals such as Journal of Clinical Medicine, Rhinology Journal, Clinical and Translational Allergy, npj Primary Care Respiratory Medicine and Allergy and Asthma Proceedings.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.